164 related articles for article (PubMed ID: 6588281)
1. Ontogeny of N,N-dimethyltryptamine and related indolealkylamine levels in neonatal rats.
Beaton JM; Morris PE
Mech Ageing Dev; 1984 Jun; 25(3):343-7. PubMed ID: 6588281
[TBL] [Abstract][Full Text] [Related]
2. Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC-APcI-MS-MS-isotope dilution method.
Barker SA; Littlefield-Chabaud MA; David C
J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(1):37-47. PubMed ID: 11232854
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
McKenna DJ; Towers GH; Abbott F
J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the synthesis of N,N-dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry.
Brandt SD; Moore SA; Freeman S; Kanu AB
Drug Test Anal; 2010 Jul; 2(7):330-8. PubMed ID: 20648523
[TBL] [Abstract][Full Text] [Related]
5. Identification and quantification of 1,2,3,4-tetrahydro-beta-carboline, 2-methyl-1,2,3,4-tetrahydro-beta-carboline, and 6-methoxy-1,2,3,4-tetrahydro-beta-carboline as in vivo constituents of rat brain and adrenal gland.
Barker SA; Harrison RE; Monti JA; Brown GB; Christian ST
Biochem Pharmacol; 1981 Jan; 30(1):9-17. PubMed ID: 7213417
[No Abstract] [Full Text] [Related]
6. Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect.
Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
Biochem Pharmacol; 1982 Aug; 31(15):2513-6. PubMed ID: 6812592
[TBL] [Abstract][Full Text] [Related]
7. GC/MS quantification and identification of endogenous tetrahydro-beta-carbolines in rat brain and adrenal.
Barker SA
Prog Clin Biol Res; 1982; 90():113-24. PubMed ID: 6810379
[No Abstract] [Full Text] [Related]
8. In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat.
Sitaram BR; Lockett L; Talomsin R; Blackman GL; McLeod WR
Biochem Pharmacol; 1987 May; 36(9):1509-12. PubMed ID: 3472526
[TBL] [Abstract][Full Text] [Related]
9. Study of metabolism of psychotomimetic indolealkylamines by rat tissue extracts using liquid chromatography.
Sitaram BR; Talomsin R; Blackman GL; McLeod WR
Biochem Pharmacol; 1987 May; 36(9):1503-8. PubMed ID: 3472525
[TBL] [Abstract][Full Text] [Related]
10. In vivo metabolism of alpha,alpha,beta,beta-tetradeutero-N, N-dimethyltryptamine in rodent brain.
Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
Biochem Pharmacol; 1984 May; 33(9):1395-400. PubMed ID: 6587850
[TBL] [Abstract][Full Text] [Related]
11. N,N-dimethyltryptamine like substance in rat brain.
Heller B; Fischer E; Spats H
Life Sci; 1973 Aug; 13(4):313-6. PubMed ID: 4518592
[No Abstract] [Full Text] [Related]
12. Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans.
Barman R; Kumar Bora P; Saikia J; Konwar P; Sarkar A; Kemprai P; Proteem Saikia S; Haldar S; Slater A; Banik D
Phytochemistry; 2024 Feb; 218():113928. PubMed ID: 38035973
[TBL] [Abstract][Full Text] [Related]
13. 11C-labeling of indolealkylamine alkaloids and the comparative study of their tissue distributions.
Takahashi T; Takahashi K; Ido T; Yanai K; Iwata R; Ishiwata K; Nozoe S
Int J Appl Radiat Isot; 1985 Dec; 36(12):965-9. PubMed ID: 3866749
[TBL] [Abstract][Full Text] [Related]
14. N,N-dimethyltryptamine--a possible relationship to schizophrenia?
Wyatt RJ; Gillin JC; Kaplan J; Stillman R; Mandel L; Ahn HS; VandenHeuvel WJ; Walker RW
Adv Biochem Psychopharmacol; 1974; 11(0):299-313. PubMed ID: 4602668
[No Abstract] [Full Text] [Related]
15. Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.
Gillin JC; Wyatt RJ
Psychopharmacol Bull; 1976 Oct; 12(4):12-3. PubMed ID: 1067623
[No Abstract] [Full Text] [Related]
16. Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice.
Morinan A; Collier JG
Psychopharmacology (Berl); 1981; 75(2):179-83. PubMed ID: 6798607
[TBL] [Abstract][Full Text] [Related]
17. In vivo long-term kinetics of radiolabeled n,n-dimethyltryptamine and tryptamine.
Vitale AA; Pomilio AB; Cañellas CO; Vitale MG; Putz EM; Ciprian-Ollivier J
J Nucl Med; 2011 Jun; 52(6):970-7. PubMed ID: 21622895
[TBL] [Abstract][Full Text] [Related]
18. Indoloquinolizidines, formal derivatives of tetrahydro-beta-carbolines, show selective affinity for benzodiazepine, tryptamine and serotonin binding sites in rat brain.
Lounasmaa M; Saano V; Airaksinen MM; Jokela R; Huhtikangas A
Neuropharmacology; 1986 Aug; 25(8):915-8. PubMed ID: 3774117
[TBL] [Abstract][Full Text] [Related]
19. A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus.
Helsley S; Fiorella D; Rabin RA; Winter JC
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):649-63. PubMed ID: 9682278
[TBL] [Abstract][Full Text] [Related]
20. Indolealkylamines and prolactin secretion. A structure-activity study in the central nervous system of the rat.
Seeman G; Brown GM
Neuropharmacology; 1985 Dec; 24(12):1195-200. PubMed ID: 3867833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
